Novartis AG (ADR) (NYSE:NVS) announces Xolair® approved in EU as first and only licensed therapy for chronic spontaneous urticaria (CSU) patients unresponsive to antihistamines . Processed and transmitted by NASDAQ OMX Corporate Solutions. Novartis AG (ADR) (NYSE:NVS) stock opened at $83.19 in last session, and closed at $83.10, while the day range of stock is $82.95 – $83.39. The stock showed a positive weekly performance of 2.99%.
AstraZeneca plc (NYSE:AZN) was downgraded by research analysts at Bank of America from a “neutral” rating to an “underperform” rating in a report released on Monday, StockRatingsNetwork reports. AstraZeneca plc (ADR) (NYSE:AZN) stock opened at $67.51, in last session and closed at $67.44, by losing -0.81%. The 52 week range of the stock is $45.26 – $68.76. Company’s market capitalization is $84.96 billion.
Eli Lilly and Company (NYSE:LLY) will attend the Barclays Global Healthcare Conference on Wednesday, March 12, 2014. David Ricks, Lilly senior vice president, and president of Lilly Bio-Medicines, will participate in a fireside chat at 1:00 p.m. EDT. Eli Lilly and Co (NYSE:LLY) stock decreased -0.70% and finished the last session at $59.43. The EPS of the stock remained 4.31. Company’s market capitalization is $67.69 billion.
JPMorgan Chase & Co. reaffirmed their neutral rating on shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) in a report released on Tuesday, AR Network reports. JPMorgan Chase & Co. currently has a GBX 1,750 ($29.28) price objective on the stock. GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened the session at $56.35, and closed the session at $56.43. The 52 week range of the stock remained $44.29 – $56.73 and the day range was $56.26 – $56.60.
Leave a Reply